A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pemetrexed|DRUG: cyclophosphamide|DRUG: pemetrexed
Sponsor: Eli Lilly and Company